Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
HeartFlow (HTFL) has multiple fresh growth catalysts—Aetna coverage expansion Jan 6, 2026, new clinical data at ACC and the launch/enrollment of the 5,000‑patient NAVIGATE‑PCI registry on March 16, 2026—and its stock has surged ~20–30% off the March low, positioning it as a high‑beta, event-driven healthcare IT momentum trade despite ongoing operating losses.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Price Behavior
Key Price Behavior Insights: • Lower-high pattern • Failed rebounds • Near support Support Level: $24.0–$24.5 Resistance Level: $25.5–$26.0 HTFL is in a clear short-term downtrend over the last month, with lower highs/lows and failed bounces, though near $24.0–$24.5 support could still trigger only a tentative reflex bounce.
Sentiment & News
Key News Insights: • Clinical validation • Workflow adoption • Insider sale HeartFlow's news flow is increasingly bullish, driven by strong SCCT validation of its AI coronary plaque analysis, expanding workflow/billing prospects, and broader commercial adoption, with the CEO's share sale as the main offsetting headline.
AI Summary
HTFL now hinges less on clinical promise and more on whether rising revenue, bundled Plaque Staging, and any reimbursement tailwind can convert into durable adoption and operating leverage, because the stock's sharp downtrend and insider sale show the market still wants proof that growth is monetizable, not just scientifically credible.
Description
HeartFlow offers a non-invasive diagnostic platform that converts a single coronary CT angiogram into a patient-specific 3D heart model and applies computational fluid dynamics and related analytics to quantify blood flow, arterial narrowing, and plaque characteristics. Founded in 2007 and based in Mountain View, California, the company distributes its technology globally to support clinical assessment and management of coronary artery disease.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Mar 23 | Mar 30 | HTFL | Heartflow, Inc. Common Stock | HeartFlow (HTFL) has multiple fresh growth catalysts—Aetna coverage expansion Jan 6, 2026, new clinical data at ACC and the launch/enrollment of the 5,000‑patient NAVIGATE‑PCI registry on March 16, 2026—and its stock has surged ~20–30% off the March low, positioning it as a high‑beta, event-driven healthcare IT momentum trade despite ongoing operating losses. | Closed | -11.0% |